Ge Shufan, Sun Lanting, Wang Han, Yang Wenming, Xuan Qiaoyu, Hua Daiping
Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China.
Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine, Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China.
Front Neurol. 2025 Mar 12;16:1514044. doi: 10.3389/fneur.2025.1514044. eCollection 2025.
Wilson's disease (WD) and Alexander's disease (AxD) are two prevalent genetic illnesses in clinical practice. However, cases of concurrent WD and AxD have not been reported. A mutation in the ATP7B gene causes improper copper metabolism, whereas AxD is caused by a mutation in the GFAP gene, which causes glial fibrillary acidic protein to accumulate in astrocytes. We present the first instance of concurrent WD and AxD in order to increase the diagnosis accuracy of this type of disease and provide a more precise treatment plan for the patient. A 10-year-old girl who appeared with diminished speech, limb weakness, trouble walking, and mental behavioral problems within the last 2 months. The patient's copper biochemistry results and clinical manifestations supported the diagnosis of WD, however her uncommon bilateral frontal lobe cerebral white matter with considerable high signal in MRI differed from the normal neuroimaging presentations of WD. To clarify the patient's diagnosis, we did whole-exome sequencing testing. To further clarify the patient's diagnosis, we performed whole exome sequencing tests on the patient and her father and detected a single heterozygous mutation in the GFAP gene and a double heterozygous mutation in the ATP7B gene, with the two variant loci located on the same allele. Combined with the Leipzig score and characteristic MRI changes, the patient was diagnosed with co-morbid WD and AxD. The overlapping presentation of the two diseases on MRI suggests the importance of clinicians recognizing the features of both diseases. A comprehensive diagnostic strategy including genetic testing, neuroimaging, and detailed clinical evaluation is required.
威尔逊病(WD)和亚历山大病(AxD)是临床实践中两种常见的遗传性疾病。然而,WD和AxD并发的病例尚未见报道。ATP7B基因突变会导致铜代谢异常,而AxD是由GFAP基因突变引起的,该突变会导致胶质纤维酸性蛋白在星形胶质细胞中蓄积。我们报告首例WD和AxD并发病例,以提高此类疾病的诊断准确性,并为患者提供更精准的治疗方案。一名10岁女孩在过去2个月内出现言语减少、肢体无力、行走困难及精神行为问题。患者的铜生化检查结果及临床表现支持WD诊断,但其MRI表现为双侧额叶脑白质罕见的高信号,与WD的正常神经影像学表现不同。为明确患者诊断,我们进行了全外显子组测序检测。为进一步明确诊断,我们对患者及其父亲进行了全外显子组测序检测,在GFAP基因检测到一个杂合突变,在ATP7B基因检测到两个杂合突变,两个变异位点位于同一等位基因上。结合莱比锡评分及特征性MRI改变,该患者被诊断为WD和AxD共病。两种疾病在MRI上的重叠表现提示临床医生认识两种疾病特征的重要性。需要一种包括基因检测、神经影像学及详细临床评估的综合诊断策略。